The UK Prostate Cancer Clinical Research Strategy Group logo

UK Prostate Cancer Clinical Research Strategy Group

In light of the National Cancer Research Institute (NCRI) winding down, the NCRI Prostate Group has been re-established as the UK Prostate Cancer Clinical Research Strategy Group – the CRSG.

The CRSG brings together experts from across the prostate cancer research community to help shape the future of clinical research in the UK — keeping the focus on what matters most to men affected by prostate cancer.

What is the aim of the CRSG?

  • Identify key gaps in clinical prostate cancer research

  • Shape the national research landscape

  • Strengthen research applications by offering expert input early in study design and development

April CRSG meeting
CRSG members and Early Career members at the April 2026 meeting

What does the CRSG do?

Spotting what's missing:

The group will help identify important gaps in clinical prostate cancer research and shape the studies needed for men over the next five to ten years.

Offering early support:

The group will give expert advice and guidance to strengthen clinical research ideas and study designs at early stages of development.

Working openly and together:

The group aims to be transparent, supportive, and collaborative - helping everyone in the prostate cancer research community make their clinical studies as strong and impactful as possible, as quickly as possible.

Supporting new researchers:

The group will offer guidance and mentorship to early career researchers to help them develop their skills and build successful careers in prostate cancer research.

Staying focussed:

The group won't be responsible for managing trial delivery, reviewing policies, or tracking research portfolios. Its focus is on strategy, advice, and research development.

We’re recruiting a new Chair of the CRSG

Lead and shape UK prostate cancer clinical research.

Expressions of interest for the Chair of the CRSG closed on Monday 22 June.

We are now reviewing submissions and will progress to shortlisting and, if required, interviews in the coming weeks. An update will be shared once the appointment has been confirmed.

CRSG Chair role specification
Prof Hashim Ahmed shares reflections on leading the CRSG and working with the research community to shape clinical prostate cancer research in the UK.

CRSG Chair recruitment timeline

  • Expressions of Interest closed: Monday 22 June

  • Review and shortlisting: Currently underway

  • Interviews: If required, to take place in July

  • Appointment confirmed: Expected by August

Upcoming CRSG meetings

The next CRSG meetings will take place on:

  • Thursday 11 September 2026

  • Friday 12 March 2027

Further details will be shared soon.

Governance and partnerships

The CRSG operates as part of the UK Clinical Cancer Research Collaboration (UK3CR), supporting coordination and collaboration across the UK cancer research landscape, with light‑touch oversight.

The group works in line with an agreed Terms of Reference, which set out its role, responsibilities and ways of working.

UK3CR-logo-blue-on-white-3000x2000px-JPG.jpg

The CRSG Member Terms of Reference Sets out the role, responsibilities and ways of working for CRSG members, including expectations for participation, decision‑making and contribution to the group’s strategic discussions. 

The CRSG Early Career member Terms of Reference are tailored guidance for early career members, outlining their role in contributing to discussions, developing skills and engaging with the group in a supportive, developmental environment.

The UK Clinical Cancer Research Collaboration (UK3CR) terms of reference outlines their role in supporting coordination across the UK cancer research landscape, including the principles and light‑touch governance framework that strategy groups such as the CRSG operate within.